DE20004692U1
(de)
|
2000-03-14 |
2001-07-26 |
Sofamor Danek Gmbh |
Wirbelimplantat zum Einschrauben in einen Wirbelzwischenraum
|
ES2213745T3
(es)
*
|
1993-05-12 |
2004-09-01 |
Genetics Institute, Llc |
Composiciones de bmp-11.
|
US5906827A
(en)
*
|
1994-06-03 |
1999-05-25 |
Creative Biomolecules, Inc. |
Matrix for the manufacture of autogenous replacement body parts
|
US5846770A
(en)
*
|
1994-11-22 |
1998-12-08 |
Genetics Institute, Inc. |
DNA molecules encoding human chordin
|
US5645084A
(en)
*
|
1995-06-07 |
1997-07-08 |
Danek Medical, Inc. |
Method for spinal fusion without decortication
|
US5635372A
(en)
*
|
1995-05-18 |
1997-06-03 |
Genetics Institute, Inc. |
BMP-15 compositions
|
PT831884E
(pt)
|
1995-06-05 |
2003-11-28 |
New York Society |
Uso de proteinas morfogeneticas do caso para cicatrizacao e reparacao da ligacao do tecido conjuntivo
|
US5902785A
(en)
*
|
1995-06-06 |
1999-05-11 |
Genetics Institute, Inc. |
Cartilage induction by bone morphogenetic proteins
|
US5989289A
(en)
|
1995-10-16 |
1999-11-23 |
Sdgi Holdings, Inc. |
Bone grafts
|
US6423095B1
(en)
|
1995-10-16 |
2002-07-23 |
Sdgi Holdings, Inc. |
Intervertebral spacers
|
US5700774A
(en)
*
|
1996-03-26 |
1997-12-23 |
Genetics Institute, Inc. |
Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
|
US5965403A
(en)
|
1996-09-18 |
1999-10-12 |
Genetics Institute, Inc. |
Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
|
EP0955961B1
(en)
|
1996-10-23 |
2004-03-31 |
SDGI Holdings, Inc. |
Spinal spacer
|
US6037519A
(en)
*
|
1997-10-20 |
2000-03-14 |
Sdgi Holdings, Inc. |
Ceramic fusion implants and compositions
|
JP4388602B2
(ja)
|
1997-02-07 |
2009-12-24 |
ストライカー コーポレイション |
マトリクスを含まない骨形成デバイス、移植片、およびその使用方法
|
US7041641B2
(en)
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
US20010016646A1
(en)
|
1998-03-20 |
2001-08-23 |
David C. Rueger |
Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
|
TW562807B
(en)
*
|
1997-04-01 |
2003-11-21 |
Chugai Pharmaceutical Co Ltd |
Novel secretory membrane protein
|
AU742663B2
(en)
|
1997-05-30 |
2002-01-10 |
Stryker Corporation |
Methods for evaluating tissue morphogenesis and activity
|
US5972368A
(en)
*
|
1997-06-11 |
1999-10-26 |
Sdgi Holdings, Inc. |
Bone graft composites and spacers
|
US20020052026A1
(en)
|
1997-10-08 |
2002-05-02 |
Steven M. Vicik |
Methods of refolding proteins
|
US6511509B1
(en)
|
1997-10-20 |
2003-01-28 |
Lifenet |
Textured bone allograft, method of making and using same
|
WO1999029719A2
(en)
*
|
1997-12-09 |
1999-06-17 |
Ontogeny, Inc. |
Pancreatic-derived factors, and uses related thereto
|
US6027917A
(en)
*
|
1997-12-10 |
2000-02-22 |
Genetics Institute, Inc. |
Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
|
US7147839B2
(en)
|
1998-05-29 |
2006-12-12 |
Curis, Inc. |
Methods for evaluating tissue morphogenesis and activity
|
JP4156197B2
(ja)
|
1998-08-06 |
2008-09-24 |
ウォーソー・オーソペディック・インコーポレーテッド |
複合型椎骨間スペーサ
|
ES2326467T3
(es)
|
2000-12-08 |
2009-10-13 |
Osteotech, Inc. |
Implante para aplicaciones ortopedicas.
|
US6752831B2
(en)
|
2000-12-08 |
2004-06-22 |
Osteotech, Inc. |
Biocompatible osteogenic band for repair of spinal disorders
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
US7741098B2
(en)
*
|
2001-11-27 |
2010-06-22 |
Nexyte Ab |
Production of eukaryotic proteins and nucleic acid molecules in C. elegans
|
CH695985A5
(de)
|
2002-01-21 |
2006-11-15 |
Straumann Holding Ag |
Oberflächenmodifizierte Implantate.
|
WO2003093314A2
(en)
|
2002-05-03 |
2003-11-13 |
Millenium Biologix Inc. |
Connective tissue stimulating peptides
|
SI1675608T1
(sl)
|
2003-09-12 |
2007-08-31 |
Wyeth Corp |
Injektibilne trdne paličice kalcijevega fosfata za dajanje osteogenih proteinov
|
CA2558395C
(en)
|
2004-03-10 |
2011-11-29 |
Scil Technology Gmbh |
Coated implants, their manufacturing and use thereof
|
EP1732589A2
(en)
|
2004-03-26 |
2006-12-20 |
Acceleron Pharma Inc. |
Bmp-3 propeptides and related methods
|
US7575751B2
(en)
|
2004-04-27 |
2009-08-18 |
Research Development Foundation |
Activin-A mutants
|
US7741284B2
(en)
|
2004-05-12 |
2010-06-22 |
Acceleron Pharma Inc. |
BMP10 propeptides and related methods
|
ATE515268T1
(de)
|
2004-05-25 |
2011-07-15 |
Stryker Corp |
Verwendung von op-1 zur behandlung von knorpeldefekten
|
US7749268B2
(en)
|
2004-05-26 |
2010-07-06 |
Warsaw Orthopedic, Inc. |
Methods for treating the spine
|
EP1771557B1
(en)
|
2004-06-24 |
2014-12-31 |
Acceleron Pharma Inc. |
GDF3 Propeptides and Related Methods
|
EP3489257A1
(en)
|
2004-07-23 |
2019-05-29 |
Acceleron Pharma Inc. |
Actrii receptor polypeptides, methods and compositions
|
US7473678B2
(en)
|
2004-10-14 |
2009-01-06 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods of use thereof
|
RS58231B1
(sr)
|
2005-11-23 |
2019-03-29 |
Acceleron Pharma Inc |
Antagonisti aktivin-actriia i primene za stimulaciju rasta kostiju
|
US8128933B2
(en)
|
2005-11-23 |
2012-03-06 |
Acceleron Pharma, Inc. |
Method of promoting bone growth by an anti-activin B antibody
|
US8147860B2
(en)
|
2005-12-06 |
2012-04-03 |
Etex Corporation |
Porous calcium phosphate bone material
|
WO2007092622A2
(en)
|
2006-02-09 |
2007-08-16 |
Biomimetic Therapeutics, Inc. |
Compositions and methods for treating bone
|
EP2035030A2
(en)
|
2006-05-17 |
2009-03-18 |
Stryker Corporation |
Use of a soluble morphogenic protein complex for treating cartilage defects
|
JP5484047B2
(ja)
|
2006-06-30 |
2014-05-07 |
バイオミメティック セラピューティクス, エルエルシー |
回旋筋腱板傷害を処置するためのpdgf−生体マトリックス組成物および方法
|
US9161967B2
(en)
|
2006-06-30 |
2015-10-20 |
Biomimetic Therapeutics, Llc |
Compositions and methods for treating the vertebral column
|
AU2007234612B2
(en)
|
2006-12-14 |
2013-06-27 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein stabilization formulations
|
US8895016B2
(en)
|
2006-12-18 |
2014-11-25 |
Acceleron Pharma, Inc. |
Antagonists of activin-actriia and uses for increasing red blood cell levels
|
US20100184659A1
(en)
|
2006-12-21 |
2010-07-22 |
Warren Jaworowicz |
Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents
|
TWI584815B
(zh)
|
2007-02-01 |
2017-06-01 |
艾瑟勒朗法瑪公司 |
活化素-ActRIIa拮抗劑及其治療或預防乳癌之用途
|
TW201907946A
(zh)
|
2007-02-02 |
2019-03-01 |
美商艾瑟勒朗法瑪公司 |
衍生自ActRIIB的變體與其用途
|
EA018221B1
(ru)
|
2007-02-09 |
2013-06-28 |
Акселерон Фарма Инк. |
АНТАГОНИСТЫ АКТИВИНА-ActRIIa И ПРИМЕНЕНИЕ ДЛЯ СТИМУЛЯЦИИ РОСТА КОСТИ У БОЛЬНЫХ РАКОМ
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
US8058237B2
(en)
|
2007-08-07 |
2011-11-15 |
Advanced Technologies & Regenerative Medicine, LLC |
Stable composition of GDF-5 and method of storage
|
CN103877564A
(zh)
|
2007-09-18 |
2014-06-25 |
阿塞勒隆制药公司 |
活化素-actriia拮抗剂和减少或抑制fsh分泌的用途
|
AU2009214629A1
(en)
|
2008-02-13 |
2009-08-20 |
Eric T. Choi |
BMP-7 for use in treating vascular sclerosis
|
AU2009236459B2
(en)
|
2008-04-14 |
2013-07-25 |
Advanced Technologies And Regenerative Medicine, Llc |
Liquid buffered GDF-5 formulations
|
US8216997B2
(en)
|
2008-08-14 |
2012-07-10 |
Acceleron Pharma, Inc. |
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
|
PL3494986T3
(pl)
|
2008-08-14 |
2020-11-16 |
Acceleron Pharma Inc. |
Pułapki GDF
|
MX2011002555A
(es)
|
2008-09-09 |
2011-08-03 |
Biomimetic Therapeutics Inc |
Composiciones de factor de crecimiento derivadas de plaquetas y metodo para el tratamiento de lesiones de tendon y ligamentos.
|
EP2387412A4
(en)
|
2009-01-13 |
2013-04-03 |
Acceleron Pharma Inc |
METHODS FOR INCREASING ADIPONECTIN
|
US20100204124A1
(en)
|
2009-02-12 |
2010-08-12 |
Mary Elizabeth Pecquet Goad |
Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members
|
WO2010093925A2
(en)
|
2009-02-12 |
2010-08-19 |
Stryker Corporation |
PERIPHERAL ADMINISTRATION OF PROTEINS INCLUDING TGF-β SUPERFAMILY MEMBERS FOR TREATMENT OF SYSTEMIC DISORDERS AND DISEASE
|
US20120148539A1
(en)
|
2009-03-24 |
2012-06-14 |
Moulay Hicham Alaoui-Ismaili |
Methods and Compositions for Tissue Engineering
|
AU2010258931B2
(en)
|
2009-06-08 |
2015-04-23 |
Acceleron Pharma Inc. |
Methods for increasing thermogenic adipocytes
|
US20110002897A1
(en)
|
2009-06-11 |
2011-01-06 |
Burnham Institute For Medical Research |
Directed differentiation of stem cells
|
WO2010151426A1
(en)
|
2009-06-12 |
2010-12-29 |
Acceleron Pharma Inc. |
Truncated actriib-fc fusion proteins
|
US9399086B2
(en)
|
2009-07-24 |
2016-07-26 |
Warsaw Orthopedic, Inc |
Implantable medical devices
|
WO2011031856A1
(en)
|
2009-09-09 |
2011-03-17 |
Stryker Corporation |
Bmp -7 for use in treating pain induced by injuries and diseases of an articular joint
|
JP2013518808A
(ja)
|
2009-09-17 |
2013-05-23 |
ストライカー コーポレイション |
骨形成タンパク質のpHを制御するための緩衝液
|
EP2501400B1
(en)
|
2009-11-17 |
2017-11-01 |
Acceleron Pharma, Inc. |
Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
|
EP2516456A1
(en)
|
2009-12-22 |
2012-10-31 |
Stryker Corporation |
Bmp-7 variants with reduced immunogenicity
|
CN102811622A
(zh)
|
2010-02-22 |
2012-12-05 |
生物模拟治疗公司 |
用于治疗腱病的血小板衍生生长因子组合物和方法
|
WO2011139594A2
(en)
|
2010-04-27 |
2011-11-10 |
Medtronic, Inc. |
Artificial bursa for intra-articular drug delivery
|
EP2638065A4
(en)
|
2010-11-08 |
2014-04-09 |
Acceleron Pharma Inc |
ACTRIIA BINDING AGENTS AND USES THEREOF
|
US9809636B2
(en)
|
2012-04-06 |
2017-11-07 |
Acceleron Pharma Inc. |
Methods for increasing red blood cell levels comprising administering BMP9
|
US10034945B2
(en)
|
2012-07-13 |
2018-07-31 |
Trustees Of Tufts College |
Silk powder compaction for production of constructs with high mechanical strength and stiffness
|
AU2013337677B2
(en)
|
2012-11-02 |
2018-06-28 |
Celgene Corporation |
Activin-ActRII antagonists and uses for treating bone and other disorders
|
US9572912B2
(en)
|
2013-04-19 |
2017-02-21 |
Theracell, Inc. |
Demineralized bone fibers having controlled geometry and shapes and methods thereof
|
US9850298B2
(en)
|
2014-06-13 |
2017-12-26 |
Acceleron Pharma Inc. |
Methods for treating ulcers in thalassemia syndrome with an ActRIIB polypeptide
|
GB201412290D0
(en)
|
2014-07-10 |
2014-08-27 |
Cambridge Entpr Ltd |
Novel use
|
MA41052A
(fr)
|
2014-10-09 |
2017-08-15 |
Celgene Corp |
Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
|
RS64214B1
(sr)
|
2014-12-03 |
2023-06-30 |
Celgene Corp |
Antagonisti aktivin-actrii i njihova primena u lečenju mijelodisplastičnog sindroma
|
WO2016123583A1
(en)
|
2015-01-29 |
2016-08-04 |
Theracell, Inc. |
Demineralized bone fiber composition for use in minimally invasive surgery
|
EP3834816A1
(en)
|
2015-06-17 |
2021-06-16 |
Warsaw Orthopedic, Inc. |
Implants including an oxysterol and methods of use
|
ES2846848T3
(es)
|
2015-10-26 |
2021-07-29 |
Harvard College |
Polisacáridos reducidos y oxidados y métodos de uso de los mismos
|
US10688222B2
(en)
|
2016-11-21 |
2020-06-23 |
Warsaw Orthopedic, Inc. |
Lyophilized moldable implants containing an oxysterol
|
US10639157B2
(en)
|
2017-03-14 |
2020-05-05 |
Theracell, Inc. |
Demineralized bone fiber composition for use in minimally invasive surgery
|
US11464888B2
(en)
|
2017-06-12 |
2022-10-11 |
Warsaw Orthopedic, Inc. |
Moldable formulations containing an oxysterol in an acellular tissue matrix
|
US11103618B2
(en)
|
2018-02-22 |
2021-08-31 |
Warsaw Orthopedic, Inc. |
Demineralized bone matrix having improved handling characteristics
|
US11498880B2
(en)
|
2019-07-26 |
2022-11-15 |
Warsaw Orthopedic, Inc. |
Calcium phosphate granules and methods of making them
|
CN113603792B
(zh)
*
|
2021-08-26 |
2023-06-30 |
深圳市人民医院 |
一种重组骨形态发生蛋白-2及其制备方法和应用
|